single
LL-Tirz
30mg
Dual GIP & GLP-1 receptor research specimen · 30mg
The Coast to Lab Initiative
This order ships with a hand-picked seashell from Gulf Shores & Santa Rosa — a small piece of the coast, tucked inside every box.
Technical Specifications
View COA- Purity
- >99%
- Batch No.
- sample_tz30_GLP_TZ
- Storage
- Store below -20°C. Protect from light.
Certificate of Analysis Pending
- Purity
- >99% HPLC
- Testing method
- High-Performance Liquid Chromatography
- Batch ID
- sample_tz30_GLP_TZ
- Verify
- Request the COA by email
For Research Use Only. Not For Human Consumption.
Description
Tirzepatide is a synthetic peptide combining glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists. Formulated specifically for laboratory investigation and receptor binding assays.
Questions about LL-Tirz
What is GLP-TZ (Tirzepatide)?
GLP-TZ is a synthetic dual agonist targeting both GLP-1 and GIP receptors simultaneously. It is studied in laboratory research for the synergistic effects of dual incretin receptor activation and downstream metabolic signaling pathways. For research use only.
What is the difference between GLP-TZ and GLP-RT?
GLP-TZ (Tirzepatide) is a dual GLP-1/GIP agonist. GLP-RT (Retatrutide) is a triple GLP-1/GIP/glucagon agonist. GLP-TZ allows researchers to study dual-receptor dynamics in isolation from glucagon pathway effects.
